Shares of Portola Pharmaceuticals, Inc. (PTLA) have traded between $12.63 – 37.96. The next earnings date is set for Feb 26, 2020. Let’s see how its prospects are shaping up.

What does Portola Pharmaceuticals, Inc.(PTLA) do?

Portola Pharmaceuticals, Inc. engages in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders and inflammation. It offers Andexxa, and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.

PTLA Insider Trading Insight

On 2019-11-01, Renton Hollings Dir sold 5,000 shares of PTLA. That represents a value of $16,020. Not to be outdone, on 2019-08-08, Renton Hollings S – Sale+OE sold5,000 shares of PTLA. These insiders are clearly in the know because they work closely with the company.

CRI Intraday Trading

CRI is due to report earnings on Feb 24, 2020. In the last year the price has ranged from 81.55 – 112.46. Recently, Foglesong Greg sold 4,125 shares of CRI. He is a $2,038,600 shareholder in CRI.

Looking for stocks similar to PTLA and CRI?

Here are some stocks to consider: